Procter & Gamble Hygiene & Health Care Ltd.

As of June 30, 2026, Procter & Gamble Hygiene & Health Care Ltd. carries a market capitalization of 294.87B, placing it among publicly traded companies globally. Its enterprise value stands at 294.87B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Procter & Gamble Hygiene & Health Care Ltd.'s next confirmed earnings release is scheduled for November 5, 2026.

As of June 30, 2026, Procter & Gamble Hygiene & Health Care Ltd. has 32.46M shares outstanding.

As of June 30, 2026, Procter & Gamble Hygiene & Health Care Ltd. trades at a trailing price-to-earnings ratio of 37.29.

As of June 30, 2026, Procter & Gamble Hygiene & Health Care Ltd. trades at an EV/EBITDA multiple of 27.43 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 6.96 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 28.44 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 294.87B versus a market cap of 294.87B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 51.73M in revenue per employee across its workforce of 819.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Procter & Gamble Hygiene & Health Care Ltd. recorded 2.81B in income tax expense. That works out to an effective tax rate of 26.21, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 10.72B, leaving 7.91B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, Procter & Gamble Hygiene & Health Care Ltd.'s stock has declined approximately 50.20% over the past 52 weeks. The 50-day moving average sits at 7,503.14, while the 200-day moving average is 9,518.67.

Over the twelve months ended June 30, 2026, Procter & Gamble Hygiene & Health Care Ltd. generated 42.36B in revenue and converted that into 7.91B in net income, yielding earnings per share of 243.59. EBITDA reached 10.75B, while operating income came in at 10.37B.

Over the twelve months ended June 30, 2026, Procter & Gamble Hygiene & Health Care Ltd. posted a gross margin of 62.13, reflecting its pricing power and cost economics. The operating margin of 24.48 and net profit margin of 18.67 provide insight into operational efficiency.

Procter & Gamble Hygiene & Health Care Ltd.'s most recent stock split took place on December 10, 2003 with a 2:3 split ratio.